Candel Therapeutics, Inc.
USD8.42
-0.09 (-1.06%)
CEO
Paul-Peter Tak
IPO Date
2021-07-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$8.52
Prev. Close
$8.51
Day Low
$8.07
Day High
$8.60
52W Low
$4.35
52W High
$9.27
Market Cap
$0.46B
Volume
1.72M
| 2,795 |
| $4.90 |
| 2 Apr 2026 | Loggia Nicoletta | director | A-Award | Acquired | 779 | $4.90 |
| 26 Feb 2026 | Manning Paul B | director | P-Purchase | Acquired | 550,458 | $5.45 |
| 28 Jan 2026 | Tyagarajan Seshu | Chief Technology Officer | A-Award | Acquired | 154,000 | $6.01 |
| 28 Jan 2026 | Nichols William Garrett | Chief Medical Officer | A-Award | Acquired | 136,500 | $6.01 |
| 28 Jan 2026 | Schoch Charles | Chief Financial Officer | A-Award | Acquired | 232,000 | $6.01 |
| 28 Jan 2026 | Tak Paul Peter | director, officer: Chief Executive Officer | A-Award | Acquired | 629,000 | $6.01 |
| 28 Jan 2026 | Barone Francesca | Chief Scientific Officer | A-Award | Acquired | 232,000 | $6.01 |
| 30 Jul 2025 | Nichols William Garrett | Chief Medical Officer | M-Exempt | Acquired | 937 | $1.29 |